Skip to main content
. 2019 Nov 13;25(6):289–295. doi: 10.5761/atcs.ra.19-00070

Table 2. Summary of selected series.

Author, year No. of GCT patients Type of incision Type of resection Survival Perioperative mortality
Kulkarni, 199111) 67 Thor: 15 Wedge: 13
Lobectomy: 1
Pneumonectomy: 1		 N/A 4.0% (for all procedures)
Tóth, 199328) 42 Uni thor: 27
Clamshell: 1
Bilat thor: 1
Sternotomy: 15		 Wedge: 30
Lobectomy: 7		 60% at 5 years N/A
Gels, 19978) 31 Thor: 31
Sternotomy: 6
Clamshell: 1		 Minimal resection: 6
Wedge: 24
Lobectomy: 1
Wedge + lobectomy: 1		 86.8% at 5 years
 		 0.0%
Cagini, 19987) 141 Uni thor: 66
Bilat thor: 15
Sternotomy: 13
Thoracoscopy: 1		 Wedge: 86
Segmentectomy: 3
Lobectomy: 8
Pneumonectomy: 3		 77% at 5 years, 2.0%
Liu, 199812) 157 Uni thor: 104
Sternotomy: 20
Clamshell: 22
Staged bilat thor: 11		 Wedge: 141
Lobectomy: 14
Pneumonectomy: 2		 68% at 5 years 0.6%
McGuire, 200318) 105 Thor: 130 N/A Fibrosis: 96% at 2 years
Teratoma: 82%
Viable cancer: 25%		 N/A
Kesler, 20059) 85 N/A Wedge: 65
Segment/lobe: 24
Pneumonectomy: 14		 42.3% at 5 years 3.7%
Pfannschmidt, 200613) 52 Thor: 69 Wedge: 53
Segmentectomy: 1
Lobectomy: 7
Pneumonectomy: 2
Other (laser, enucleation): 15		 75.8% at 5 years 0.0%
Schnorrer, 200915) 63 Thor: 55
Sternotomy: 24		 Wedge: 53
Lobectomy: 8
Bilobe: 1
Pneumonectomy: 1		 67% at 8.88 years 1.2%
Besse, 200922) 71 Uni thor: 36
Bilat thor: 34
Sternotomy: 4		 N/A 94% at 5 years N/A
Schirren, 201114) 124 Thor: 144
Sternotomy: 33
 		 Wedge: 173
Segmentectomy: 30
Laser: 29
Lobectomy: 8
Sleeve: 1		 87% at 5 years 0.5%
Kikuchi, 201710) 32 N/A Wedge: 23
Segment/lobe: 9		 73% at 5 years 0.0%
Totals 970 Thoracotomy: 738 (84%)
Sternotomy: 115 (13%)
Clamshell: 24 (3%)
VATS: 1 (0.1%)		 Wedge: 661 (77%)
Lobe/segment: 123 (14%)
Pneumonectomy: 23 (3%)
Other (laser, sleeve): 51 (6%)		 42.3–94.0% at 5 years 0.0–2.0%
 
878

bilat: bilateral; GCT: germ cell tumor; Thor: thoracotomy; Uni: unilateral; VATS: video-assisted thoracic surgery